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Rationale
Exposure to cigarette smoke (CS) is the primary cause of chronic obstructive pulmonary disease (COPD). Reactive oxygen species (ROS)
produced by CS, as well as by infiltrating inflammatory cells, in conjunction with compromised antioxidant defenses in the lungs of COPD
patients, results in oxidative stress. Oxidative stress leads to defective function of lung cells, such as airway smooth muscle cells (ASMCs),
driving airway inflammation and remodelling. Mitochondrial dysfunction caused by oxidative stress leads to changes in cell survival and
inflammatory responses. Mitochondrial transfer between mesenchymal stem cell (MSC) and airway cells has been shown to reverse
mitochondrial dysfunction in lung disease models. We investigated the effect of oxidative stress on mitochondrial function and viability of
ASMC and MSCs.
Methods
ASMCs dissected from bronchi or tracheas of healthy transplant donor lungs were treated with H O  (50 μM, 100 μM and 200 μM) or2 2
cigarette smoke extract (CSE) (10%, 25%, 50% and 75%) for 2 hrs, 4 hrs and 24 hrs. A cessation group was also included, in which the H O2 2
or CSE was removed at 4 hrs and replaced with serum-free medium for the next 20 hrs. Changes in mitochondrial membrane potential
(ΔΨm) and ROS levels were evaluated by JC-1 and MitoSOX staining respectively. Cell viability was measured by MTT assay. Human
induced-pluripotent stem cell-derived mesenchymal stem cells (iPSC-MSC) were similarly treated for 4 hrs and 24 hrs and the same
parameters were measured.
Results
CSE increased mitochondrial ROS levels (max ~10-fold; p<0.05) and reduced ΔΨm (max ~60%; p<0.05) in ASMCs in a concentration- and
time-dependent manner. The treatment with H O  increased mitochondrial ROS (max ~1.7-fold; p<0.05) and reduced ΔΨm (max ~30%;2 2
p<0.05) in a concentration- and time-dependent manner in ASMCs. Both CSE (max ~40%; p<0.05) and H O  (max ~40%; p<0.05) reduced2 2
ASMC viability in a concentration- and time-dependent manner. After removal of H O  4hrs post- exposure, mitochondrial dysfunction2 2
persisted; in contrast, removal of CSE led to partial recovery. Treatment of iPSC-MSCs with CSE and H O  also led to increased2 2
mitochondrial ROS levels, decreased ΔΨm and loss of cell viability.
Conclusions
H O  and CSE can induce mitochondrial ROS accumulation and ΔΨm and cell viability loss in ASMCs and iPSC-MSCs. Although stem cell2 2
mitochondrial transfer may be an appealing strategy for reversing mitochondrial dysfunction in disease, caution is required as stem cells
may also show mitochondrial damage under oxidative stress.
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